×
Home Current Archive Editorial board
News Contact
Review paper

Assessment of relation between neutrophil lympocyte, platelet lympocyte ratios and epicardial fat thickness in patients with ankylosing spondylitis

By
Ismail Boyraz ,
Ismail Boyraz
Contact Ismail Boyraz

Department of Physical Medicine and Rehabilitation, Abant Izzet Baysal University Medical Faculty, Turkey

Sabri Onur Caglar ,
Sabri Onur Caglar

Department of Cardiology, Koroglu Training and Research Hospital, Turkey

Fatma Erdem ,
Fatma Erdem

Department of Cardiology, Abant Izzet Baysal University Medical Faculty, Bolu, Turkey

Mehmet Yazic ,
Mehmet Yazic

Department of Cardiology, Abant Izzet Baysal University Medical Faculty, Bolu, Turkey

Selma Yazici ,
Selma Yazici

Department of Physical Medicine and Rehabilitation, Abant Izzet Baysal University Medical Faculty, Bolu, Turkey

Bunyamin Koc ,
Bunyamin Koc

Department of Physical Medicine and Rehabilitation, Abant Izzet Baysal University Medical Faculty, Bolu, Turkey

Ramazan Gunduz ,
Ramazan Gunduz

Department of Physical Therapy and Rehabilitation, Karabuk University Medical Faculty, Karabuk, Turkey

Ahmet Karakoyun
Ahmet Karakoyun

Physical Therapy and Rehabilitation of Department, Aksaray State Hospital, Aksaray, Turkey

Abstract

Aim
To investigate whether there is a relation between neutrophillymphocyte (N/L) and platelet- lymphocyte (P/L) ratios and epicardial adipose tissue (EAT) thickness in patients with ankylosing spondylitis (AS).
Methods
Thirty patients diagnosed with ankylosing spondylitis and 25 healthy people (controls) were included in the study. Age,
gender, body mass index (BMI), height, hemogram, sedimentation, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, CRP, hepatic and renal function tests, lipid profile of the all patients were recorded. Data related to duration of the disease, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI) values of the cases in the patient group were obtained. A cardiologist measured EAT thickness by ECHO in both patient and control groups.
Results
In the patient group, mean BASDAI and BASFI scores were 2.48±2.21 and 1.5±2.07, respectively. Age, gender, BMI values did not show statistically significant difference between the patient and the control groups. N/L and P/L ratios did not change significantly in the patient group having higher EAT, BASFI values and taking anti-TNF compared to the control group.
Conclusion
In patients with AS, EAT measurements, which are related to inflammatory response increase, can be used for monitoring of the risk of development of cardiac disease. We could not find the relation between EAT and N/L, P/L ratios in terms of
evaluation of inflammatory response.

References

1.
Maghraoui E, A. Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications. Eur J Intern Med. 2011. p. 554–60.
2.
Roldan C. Valvular and coronary heart disease in systemic inflammatory diseases: systemic disorders in heart disease. Heart. 2008. p. 1089–101.
3.
Yang D. Ankylosing spondylitis and cardiac abnormalities. J Cardiovasc Ultrasound. 2012. p. 23–4.
4.
Peters M, Symmons D, Mccarey D, Dijkmans B, Nicola P, Kvien T, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010. p. 325–31.
5.
Papagoras C, Voulgari P, Drosos A. Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. Clin Exp Rheumatol. 2013. p. 612–20.
6.
Willerson J, Ridker P. Inflammation as a cardiovascular risk factor. Circulation. 2004. p. I2-10.
7.
Lekakis J, Papamichael C, Cimponeriu A, Stamatelopoulos K, Papaioannou T, Kanakakis J, et al. Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis. Am J Cardiol. 2000. p. 949–52.
8.
Jeong J, Jeong M, Yun K, Oh S, Park E, Kim Y, et al. Echocardiographic epicardial fat thickness and coronary artery disease. Circ J. 2007. p. 536–9.
9.
Pierdomenico S, Pierdomenico A, Cuccurullo F, Iacobellis G. Meta-analysis of the relation of echocardiographic epicardial adipose tissue thickness and the metabolic syndrome. Am J Cardiol. 2013. p. 73–8.
10.
Inal E, Sunar I, Sarataş Ş, Eroğlu P, Inal S, Yener M. May neutrophil-lymphocyte and platelet-lymphocyte ratios indicate disease activity in ankylosing spondylitis? Arch Rheumatology. 2015. p. 130–7.
11.
Boyraz I, Koç B, Boyacı A, Tutoğlu A, Sarman H, Ozkan H. Ratio of neutrophil/lymphocyte and platelet/lymphocyte in patient with ankylosing spondylitis that are treating with anti-TNF. Int J Clin Exp Med. 2014. p. 2912–5.
12.
Resorlu H, Akbal A, Resorlu M, Gokmen F, Ates C, Uysal F, et al. Epicardial adipose tissue thickness in patients with ankylosing spondylitis. Clin Rheumatol. 2015. p. 295–9.
13.
Lima-Martínez M, Campo E, Salazar J, Paoli M, Maldonado I, Acosta C, et al. Epicardial fat thickness as cardiovascular risk factor and therapeutic target in patients with rheumatoid arthritis treated with biological and nonbiological therapies. 2014. p. 782850.
14.
Mazurek T, Zhang L, Zalewski A, Mannion J, Diehl J, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003. p. 2460–6.
15.
Ahsen A, Ulu M, Yuksel S, Demir K, Uysal M, Erdogan M, et al. As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation. 2013. p. 1357–62.
16.
Ben-Zvi I, Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat Rev Rheumatol. 2011. p. 105–12.
17.
Uslu A, Deveci K, Korkmaz S, Aydin B, Senel S, Sancakdar E, et al. Is neutrophil/lymphocyte ratio associated with subclinical inflammation and amyloidosis in patients with familial Mediterranean fever? Biomed Res Int. 2013. p. 185317.
18.
Balta S, Ozturk C. The platelet-lymphocyte ratio: A simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets. 2015. p. 680–1.
19.
Lidar M, Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med. 2007. p. 318–24.

Citation

Authors retain copyright. This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

 

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.